Tesamorelin
Synthetic GHRH Analogue — Research Grade
"A precision GHRH receptor agonist for growth hormone axis research."
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) supplied for in vitro and laboratory research purposes. It is used by researchers to study GHRH receptor activation, pituitary signaling models, and GH/IGF-1 axis interactions in controlled laboratory environments. Not for human or veterinary use.
Contact our research team to discuss purity specifications, available quantities, certificate of analysis, and shipping requirements for your laboratory.
For in vitro laboratory research use only. Not for human or veterinary consumption. A Certificate of Analysis (CoA) is provided with every order.
How It Works
In laboratory models, tesamorelin binds and activates GHRH receptors, enabling researchers to study pituitary GH release signaling, IGF-1 production pathways, and downstream metabolic effects in cell-based assay systems. Its structural design mirrors natural GHRH with improved stability for research applications.
Observed Research Endpoints
- Enables GHRH receptor binding and activation studies
- Supports GH/IGF-1 axis signaling research models
- Structurally stable analogue suitable for receptor pharmacology assays
- Well-characterized reference compound for GHRH biology research
- High purity grade for biochemical and cell-based applications
Important Considerations
- For laboratory research use only — not for human or veterinary consumption
- Handle according to institutional biosafety and chemical safety protocols
- Store under recommended conditions to maintain peptide integrity
- Requires qualified research personnel and appropriate laboratory facilities
- Dispose of in accordance with institutional waste management guidelines
Supplied as a research-grade peptide for in vitro laboratory use only. Not intended or suitable for administration to humans or animals. Compliance with all applicable institutional and regulatory requirements is mandatory.